CUI1 stringlengths 8 8 | RELA stringlengths 3 54 | CUI2 stringlengths 8 8 | Name1 stringlengths 1 2.86k ⌀ | Name2 stringlengths 1 2.86k ⌀ | Def1 stringlengths 1 8.95k ⌀ | Def2 stringlengths 1 8.95k ⌀ |
|---|---|---|---|---|---|---|
C0000399 | mapped_to | C0640843 | 3-Deazauridine | 3-nitro-3-deazauridine | 4-Hydroxy-1-(beta-D-ribofuranosyl)-2-pyridinone. Analog of uridine lacking a ring-nitrogen in the 3-position. Functions as an antineoplastic agent. | null |
C0000399 | mapped_to | C0644090 | 3-Deazauridine | 3-deazacyclopentenylcytosine | 4-Hydroxy-1-(beta-D-ribofuranosyl)-2-pyridinone. Analog of uridine lacking a ring-nitrogen in the 3-position. Functions as an antineoplastic agent. | null |
C0000399 | inverse_isa | C0280039 | 3-Deazauridine | pyrimidine analog | 4-Hydroxy-1-(beta-D-ribofuranosyl)-2-pyridinone. Analog of uridine lacking a ring-nitrogen in the 3-position. Functions as an antineoplastic agent. | An antimetabolite that affects the metabolism and utilization of pyrimidines. |
C0000399 | inverse_isa | C1511610 | 3-Deazauridine | Cytidine Triphosphate Synthetase Inhibitor | 4-Hydroxy-1-(beta-D-ribofuranosyl)-2-pyridinone. Analog of uridine lacking a ring-nitrogen in the 3-position. Functions as an antineoplastic agent. | Any substance that inhibits cytidine triphosphate synthetase, an enzyme that catalyses the rate-limiting step in the synthesis of CTP. Inhibition of cytidine triphosphate synthetase interferes with DNA, RNA, and CTP biosynthesis and can cause cell cycle arrest. |
C0000399 | subset_includes_concept | C1880653 | 3-Deazauridine | FDA Established Names and Unique Ingredient Identifier Codes Terminology | 4-Hydroxy-1-(beta-D-ribofuranosyl)-2-pyridinone. Analog of uridine lacking a ring-nitrogen in the 3-position. Functions as an antineoplastic agent. | The terminology that includes terms pertaining to FDA/USP Substance Registration System (SRS), which is to support health information technology initiatives by generating unique ingredient identifiers (UNIIs) for substances in drugs, biologics, foods, and devices. |
C0000399 | subset_includes_concept | C5447243 | 3-Deazauridine | NCI Drug Dictionary Terminology | 4-Hydroxy-1-(beta-D-ribofuranosyl)-2-pyridinone. Analog of uridine lacking a ring-nitrogen in the 3-position. Functions as an antineoplastic agent. | Terminology created to support the National Cancer Institute (NCI) Drug Dictionary. |
C0000402 | inverse_isa | C0003277 | Meglutol | Anticholesteremic Agents | An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids. It acts by interfering with the enzymatic steps involved in the conversion of acetate to hydroxymethylglutaryl coenzyme A as well as inhibiting the activity of HYDROXYMETHYLGLUTARYL COA REDUCTASES which is the rate ... | Substances used to lower plasma CHOLESTEROL levels. |
C0000402 | inverse_isa | C0014432 | Meglutol | Enzyme Inhibitors | An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids. It acts by interfering with the enzymatic steps involved in the conversion of acetate to hydroxymethylglutaryl coenzyme A as well as inhibiting the activity of HYDROXYMETHYLGLUTARYL COA REDUCTASES which is the rate ... | Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. |
C0000402 | inverse_isa | C0086440 | Meglutol | Hypolipidemic Agents | An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids. It acts by interfering with the enzymatic steps involved in the conversion of acetate to hydroxymethylglutaryl coenzyme A as well as inhibiting the activity of HYDROXYMETHYLGLUTARYL COA REDUCTASES which is the rate ... | Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. |
C0000402 | inverse_isa | C0360714 | Meglutol | Hydroxymethylglutaryl-CoA Reductase Inhibitors | An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids. It acts by interfering with the enzymatic steps involved in the conversion of acetate to hydroxymethylglutaryl coenzyme A as well as inhibiting the activity of HYDROXYMETHYLGLUTARYL COA REDUCTASES which is the rate ... | Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. |
C0000402 | mapped_to | C0047595 | Meglutol | 3-methylglutaric acid | An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids. It acts by interfering with the enzymatic steps involved in the conversion of acetate to hydroxymethylglutaryl coenzyme A as well as inhibiting the activity of HYDROXYMETHYLGLUTARYL COA REDUCTASES which is the rate ... | null |
C0000402 | mapped_to | C0613059 | Meglutol | 3-hydroxy-3-methylglutaric anhydride | An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids. It acts by interfering with the enzymatic steps involved in the conversion of acetate to hydroxymethylglutaryl coenzyme A as well as inhibiting the activity of HYDROXYMETHYLGLUTARYL COA REDUCTASES which is the rate ... | null |
C0000402 | mapped_to | C0620855 | Meglutol | 3-hydroxy-3-ethylglutaric acid | An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids. It acts by interfering with the enzymatic steps involved in the conversion of acetate to hydroxymethylglutaryl coenzyme A as well as inhibiting the activity of HYDROXYMETHYLGLUTARYL COA REDUCTASES which is the rate ... | null |
C0000402 | mapped_to | C3501492 | Meglutol | gymnopilin 1 | An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids. It acts by interfering with the enzymatic steps involved in the conversion of acetate to hydroxymethylglutaryl coenzyme A as well as inhibiting the activity of HYDROXYMETHYLGLUTARYL COA REDUCTASES which is the rate ... | null |
C0000402 | mapped_to | C3501493 | Meglutol | gymnopilin 2 | An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids. It acts by interfering with the enzymatic steps involved in the conversion of acetate to hydroxymethylglutaryl coenzyme A as well as inhibiting the activity of HYDROXYMETHYLGLUTARYL COA REDUCTASES which is the rate ... | null |
C0000402 | mapped_to | C3501494 | Meglutol | gymnopilin 3 | An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids. It acts by interfering with the enzymatic steps involved in the conversion of acetate to hydroxymethylglutaryl coenzyme A as well as inhibiting the activity of HYDROXYMETHYLGLUTARYL COA REDUCTASES which is the rate ... | null |
C0000402 | has_member | C3653853 | Meglutol | Other lipid modifying agents in ATC | An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids. It acts by interfering with the enzymatic steps involved in the conversion of acetate to hydroxymethylglutaryl coenzyme A as well as inhibiting the activity of HYDROXYMETHYLGLUTARYL COA REDUCTASES which is the rate ... | null |
C0000402 | inverse_isa | C1516000 | Meglutol | Antilipidemic Agent | An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids. It acts by interfering with the enzymatic steps involved in the conversion of acetate to hydroxymethylglutaryl coenzyme A as well as inhibiting the activity of HYDROXYMETHYLGLUTARYL COA REDUCTASES which is the rate ... | An agent that reduces plasma lipids, such as cholesterol or low density lipoproteins (LDL), acting systemically or locally (intestines) to decrease fat digestion, absorption, production, and accumulation in the plasma and reducing pathogenic atherosclerosis and thrombosis. |
C0000402 | subset_includes_concept | C1880653 | Meglutol | FDA Established Names and Unique Ingredient Identifier Codes Terminology | An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids. It acts by interfering with the enzymatic steps involved in the conversion of acetate to hydroxymethylglutaryl coenzyme A as well as inhibiting the activity of HYDROXYMETHYLGLUTARYL COA REDUCTASES which is the rate ... | The terminology that includes terms pertaining to FDA/USP Substance Registration System (SRS), which is to support health information technology initiatives by generating unique ingredient identifiers (UNIIs) for substances in drugs, biologics, foods, and devices. |
C0000404 | mapped_to | C0060093 | 3-Hydroxyacyl CoA Dehydrogenases | fatty acid oxidation complex | Enzymes that reversibly catalyze the oxidation of a 3-hydroxyacyl CoA to 3-ketoacyl CoA in the presence of NAD. They are key enzymes in the oxidation of fatty acids and in mitochondrial fatty acid synthesis. | null |
C0000404 | mapped_to | C0069976 | 3-Hydroxyacyl CoA Dehydrogenases | palmitoyl-CoA dependent dehydrogenase | Enzymes that reversibly catalyze the oxidation of a 3-hydroxyacyl CoA to 3-ketoacyl CoA in the presence of NAD. They are key enzymes in the oxidation of fatty acids and in mitochondrial fatty acid synthesis. | null |
C0000404 | mapped_to | C0297982 | 3-Hydroxyacyl CoA Dehydrogenases | 3-oxobutyryl-CoA reductase | Enzymes that reversibly catalyze the oxidation of a 3-hydroxyacyl CoA to 3-ketoacyl CoA in the presence of NAD. They are key enzymes in the oxidation of fatty acids and in mitochondrial fatty acid synthesis. | null |
C0000404 | mapped_to | C0311546 | 3-Hydroxyacyl CoA Dehydrogenases | 3-Hydroxybutyryl-CoA dehydrogenase | Enzymes that reversibly catalyze the oxidation of a 3-hydroxyacyl CoA to 3-ketoacyl CoA in the presence of NAD. They are key enzymes in the oxidation of fatty acids and in mitochondrial fatty acid synthesis. | null |
C0000404 | mapped_to | C0650689 | 3-Hydroxyacyl CoA Dehydrogenases | FOX2 protein, S cerevisiae | Enzymes that reversibly catalyze the oxidation of a 3-hydroxyacyl CoA to 3-ketoacyl CoA in the presence of NAD. They are key enzymes in the oxidation of fatty acids and in mitochondrial fatty acid synthesis. | null |
C0000404 | mapped_to | C0964052 | 3-Hydroxyacyl CoA Dehydrogenases | 2-methyl-3-hydroxybutyryl-coenzyme A dehydrogenase | Enzymes that reversibly catalyze the oxidation of a 3-hydroxyacyl CoA to 3-ketoacyl CoA in the presence of NAD. They are key enzymes in the oxidation of fatty acids and in mitochondrial fatty acid synthesis. | null |
C0000404 | mapped_to | C1137136 | 3-Hydroxyacyl CoA Dehydrogenases | Hsd17b10 protein, mouse | Enzymes that reversibly catalyze the oxidation of a 3-hydroxyacyl CoA to 3-ketoacyl CoA in the presence of NAD. They are key enzymes in the oxidation of fatty acids and in mitochondrial fatty acid synthesis. | null |
C0000404 | mapped_to | C1291230 | 3-Hydroxyacyl CoA Dehydrogenases | 3-Hydroxyacyl-CoA Dehydrogenase Deficiency | Enzymes that reversibly catalyze the oxidation of a 3-hydroxyacyl CoA to 3-ketoacyl CoA in the presence of NAD. They are key enzymes in the oxidation of fatty acids and in mitochondrial fatty acid synthesis. | null |
C0000404 | mapped_to | C1308548 | 3-Hydroxyacyl CoA Dehydrogenases | scu protein, Drosophila | Enzymes that reversibly catalyze the oxidation of a 3-hydroxyacyl CoA to 3-ketoacyl CoA in the presence of NAD. They are key enzymes in the oxidation of fatty acids and in mitochondrial fatty acid synthesis. | null |
C0000404 | mapped_to | C1313631 | 3-Hydroxyacyl CoA Dehydrogenases | HSD17B10 protein, human | Enzymes that reversibly catalyze the oxidation of a 3-hydroxyacyl CoA to 3-ketoacyl CoA in the presence of NAD. They are key enzymes in the oxidation of fatty acids and in mitochondrial fatty acid synthesis. | null |
C0000404 | mapped_to | C1451953 | 3-Hydroxyacyl CoA Dehydrogenases | hydroxyacyl-Coenzyme A dehydrogenase, type II, rat | Enzymes that reversibly catalyze the oxidation of a 3-hydroxyacyl CoA to 3-ketoacyl CoA in the presence of NAD. They are key enzymes in the oxidation of fatty acids and in mitochondrial fatty acid synthesis. | null |
C0000404 | mapped_to | C3657716 | 3-Hydroxyacyl CoA Dehydrogenases | MFE-2 protein, C elegans | Enzymes that reversibly catalyze the oxidation of a 3-hydroxyacyl CoA to 3-ketoacyl CoA in the presence of NAD. They are key enzymes in the oxidation of fatty acids and in mitochondrial fatty acid synthesis. | null |
C0000404 | mapped_to | C3659911 | 3-Hydroxyacyl CoA Dehydrogenases | YBR159W protein, S cerevisiae | Enzymes that reversibly catalyze the oxidation of a 3-hydroxyacyl CoA to 3-ketoacyl CoA in the presence of NAD. They are key enzymes in the oxidation of fatty acids and in mitochondrial fatty acid synthesis. | null |
C0000404 | exhibited_by | C1151198 | 3-Hydroxyacyl CoA Dehydrogenases | acetoacetyl-CoA reductase activity | Enzymes that reversibly catalyze the oxidation of a 3-hydroxyacyl CoA to 3-ketoacyl CoA in the presence of NAD. They are key enzymes in the oxidation of fatty acids and in mitochondrial fatty acid synthesis. | Catalysis of the reaction: (R)-3-hydroxyacyl-CoA + NADP+ = 3-oxoacyl-CoA + NADPH + H+. [EC:1.1.1.36] |
C0000407 | inverse_isa | C0079381 | 3-Hydroxyanthranilic Acid | Free Radical Scavengers | An oxidation product of tryptophan metabolism. It may be a free radical scavenger and a carcinogen. | Substances that eliminate free radicals. Among other effects, they protect PANCREATIC ISLETS against damage by CYTOKINES and prevent myocardial and pulmonary REPERFUSION INJURY. |
C0000407 | mapped_to | C0048166 | 3-Hydroxyanthranilic Acid | 4-chloro-3-hydroxyanthranilic acid | An oxidation product of tryptophan metabolism. It may be a free radical scavenger and a carcinogen. | null |
C0000407 | mapped_to | C0535576 | 3-Hydroxyanthranilic Acid | 4,6-dibromo-3-hydroxyanthranilic acid | An oxidation product of tryptophan metabolism. It may be a free radical scavenger and a carcinogen. | null |
C0000407 | mapped_to | C0647294 | 3-Hydroxyanthranilic Acid | 4-fluoro-3-hydroxyanthranilic acid | An oxidation product of tryptophan metabolism. It may be a free radical scavenger and a carcinogen. | null |
C0000407 | mapped_to | C0647296 | 3-Hydroxyanthranilic Acid | 4-bromo-3-hydroxyanthranilic acid | An oxidation product of tryptophan metabolism. It may be a free radical scavenger and a carcinogen. | null |
C0000412 | mapped_from | C0020388 | 3-hydroxyproline | hydroxyproline | null | A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation. |
C0000413 | mapped_to | C0047532 | 3-Hydroxysteroid Dehydrogenases | 3-ketosteroid reductase | Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. | null |
C0000413 | mapped_to | C0057325 | 3-Hydroxysteroid Dehydrogenases | delta(5)-3 beta-hydroxysteroid dehydrogenase | Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. | null |
C0000413 | mapped_to | C0058912 | 3-Hydroxysteroid Dehydrogenases | ecdysone oxidase | Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. | null |
C0000413 | mapped_to | C0080853 | 3-Hydroxysteroid Dehydrogenases | 3 beta-hydroxy-delta 5-C(27)-steroid dehydrogenase | Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. | null |
C0000413 | mapped_to | C0249715 | 3-Hydroxysteroid Dehydrogenases | 3 alpha-hydroxysteroid-5 beta-oxidoreductase | Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. | null |
C0000413 | mapped_to | C0286538 | 3-Hydroxysteroid Dehydrogenases | 5alpha-androstane-3alpha-hydroxysteroid dehydrogenase | Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. | null |
C0000413 | mapped_to | C0533352 | 3-Hydroxysteroid Dehydrogenases | 3-dehydroecdysone 3beta-reductase | Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. | null |
C0000413 | mapped_to | C0535160 | 3-Hydroxysteroid Dehydrogenases | 3-dehydroecdysone 3alpha-reductase | Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. | null |
C0000413 | mapped_to | C0608854 | 3-Hydroxysteroid Dehydrogenases | 3-hydroxycholanate dehydrogenase | Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. | null |
C0000413 | mapped_to | C0611742 | 3-Hydroxysteroid Dehydrogenases | NAD 3 alpha-hydroxy-5 alpha-pregnan-20-one-oxidoreductase | Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. | null |
C0000413 | mapped_to | C0634379 | 3-Hydroxysteroid Dehydrogenases | 3-alpha-hydroxyglycyrrhetinate dehydrogenase | Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. | null |
C0000413 | mapped_to | C0640605 | 3-Hydroxysteroid Dehydrogenases | 5alpha-androstane-3beta-hydroxysteroid dehydrogenase | Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. | null |
C0000413 | mapped_to | C0968468 | 3-Hydroxysteroid Dehydrogenases | DHRS9 protein, human | Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. | null |
C0000413 | mapped_to | C1311596 | 3-Hydroxysteroid Dehydrogenases | 3 beta-hydroxy-delta 5-steroid dehydrogenase, rat | Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. | null |
C0000413 | mapped_to | C1313085 | 3-Hydroxysteroid Dehydrogenases | Nsdhl protein, human | Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. | null |
C0000413 | mapped_to | C1723381 | 3-Hydroxysteroid Dehydrogenases | 3beta-hydroxysteroid dehydrogenase 4, mouse | Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. | null |
C0000413 | mapped_to | C1869879 | 3-Hydroxysteroid Dehydrogenases | Nsdhl protein, mouse | Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. | null |
C0000413 | mapped_to | C2743245 | 3-Hydroxysteroid Dehydrogenases | ERG26 protein, S cerevisiae | Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. | null |
C0000413 | mapped_to | C2931508 | 3-Hydroxysteroid Dehydrogenases | Lyngstadaas syndrome | Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. | An autosomal recessive liver disease, which was associated with numerical dental aberrations in a consanguineous Arabia Saudi family. This association suggests that the same gene is involved in both defects. General hypomineralization and enamel hypoplasia found in this family is thought to be secondary to malabsorptio... |
C0000413 | mapped_to | C3493736 | 3-Hydroxysteroid Dehydrogenases | DHS-16 protein, C elegans | Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. | null |
C0000413 | mapped_to | C3529452 | 3-Hydroxysteroid Dehydrogenases | At2g26260 protein, Arabidopsis | Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. | null |
C0000413 | mapped_to | C3529453 | 3-Hydroxysteroid Dehydrogenases | At1g47290 protein, Arabidopsis | Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. | null |
C0000413 | mapped_to | C4547029 | 3-Hydroxysteroid Dehydrogenases | befunolol reductase | Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. | null |
C0000424 | inverse_isa | C0009950 | 3-Mercaptopropionic Acid | Convulsants | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. |
C0000424 | inverse_isa | C0014432 | 3-Mercaptopropionic Acid | Enzyme Inhibitors | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. |
C0000424 | inverse_isa | C0242898 | 3-Mercaptopropionic Acid | GABA Agents | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | Substances used for their pharmacological actions on GABAergic systems. GABAergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function. |
C0000424 | mapped_to | C0046305 | 3-Mercaptopropionic Acid | 2-mercaptomethyl-3-guanidinoethylthiopropionic acid | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | null |
C0000424 | mapped_to | C0073061 | 3-Mercaptopropionic Acid | rentiapril | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | A potent angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. Rentiapril competitively binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the potent vasoconstrictive actions of angiotensin II and results in vasodilation. Rentiapril also ... |
C0000424 | mapped_to | C0087456 | 3-Mercaptopropionic Acid | (4R)-3-((2S)-3-mercapto-2-methylpropanoyl)-4- thiazolidinecarboxylic acid | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | null |
C0000424 | mapped_to | C0092650 | 3-Mercaptopropionic Acid | 2-benzyl-3-mercaptopropanoic acid | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | null |
C0000424 | mapped_to | C0606603 | 3-Mercaptopropionic Acid | Letterflex urethane photoprepolymer mixture | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | null |
C0000424 | mapped_to | C0616589 | 3-Mercaptopropionic Acid | 2-benzyl-3-mercaptopropanoyl-alanylglycinamide | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | null |
C0000424 | mapped_to | C0891587 | 3-Mercaptopropionic Acid | 2-mercaptomethyl-5-guanidinopentanoic acid | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | null |
C0000424 | mapped_to | C1570288 | 3-Mercaptopropionic Acid | pentaerythritol tetra(3-mercaptopropionate) | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | null |
C0000424 | mapped_to | C1743920 | 3-Mercaptopropionic Acid | S-(4,4'-dimethoxytrityl)-3-mercaptopropionic acid | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | null |
C0000424 | mapped_to | C1871588 | 3-Mercaptopropionic Acid | 2-ethylhexyl-3-mercaptopropionic acid | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | null |
C0000424 | mapped_to | C1999506 | 3-Mercaptopropionic Acid | 2-(4-fluorobenzylideneamino)-3-mercaptopropanoic acid | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | null |
C0000424 | mapped_to | C2000505 | 3-Mercaptopropionic Acid | dimethylbutyryl-S-methyl mercaptopropionate | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | null |
C0000424 | mapped_to | C2352555 | 3-Mercaptopropionic Acid | 2-omega-phenylpropyl-3-mercaptopropionic acid | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | null |
C0000424 | mapped_to | C2604579 | 3-Mercaptopropionic Acid | ethyl 3-mercaptopropionate | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | null |
C0000424 | mapped_to | C2933839 | 3-Mercaptopropionic Acid | 3-(4-(2-(5-ethylpyridine-2yl) ethoxy) phenyl)-2-mercaptopropanoic acid | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | null |
C0000424 | mapped_to | C3492277 | 3-Mercaptopropionic Acid | S-nitroso-3-mercaptopropionic acid | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | null |
C0000424 | mapped_to | C3492619 | 3-Mercaptopropionic Acid | 2-((4-(((2-methoxyethyl)(6-(3-(trifluoromethyl)phenyl)pyrimidin-4-yl)amino)methyl)phenyl)sulfanyl)-2-methylpropanoic acid | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | null |
C0000424 | mapped_to | C3884585 | 3-Mercaptopropionic Acid | poly(ethylene glycol) diacrylate-pentaerythritol tetrakis(3-mercaptopropionate) | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | null |
C0000424 | mapped_to | C4043042 | 3-Mercaptopropionic Acid | pentaerythriol tetra(3-mercaptopropionate) | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | null |
C0000424 | mapped_to | C4043627 | 3-Mercaptopropionic Acid | N-(4-hydroxyphenethyl)-3-mercapto-2-methylpropanamide | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | null |
C0000424 | mapped_to | C4078294 | 3-Mercaptopropionic Acid | dodecyl 3-(3-dodecoxy-3-oxopropyl)sulfanylpropanoate | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | null |
C0000424 | mapped_to | C4307659 | 3-Mercaptopropionic Acid | trimethylolpropane tris(3-mercaptopropionate | An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. | null |
C0000435 | associated_with | C0023195 | 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase | Familial lecithin cholesterol acyltransferase deficiency | An enzyme of long-chain fatty acid synthesis, that adds a two-carbon unit from malonyl-(acyl carrier protein) to another molecule of fatty acyl-(acyl carrier protein), giving a beta-ketoacyl-(acyl carrier protein) with the release of carbon dioxide. EC 2.3.1.41. | An autosomal recessive disorder of lipoprotein metabolism caused by mutation of LECITHIN CHOLESTEROL ACYLTRANSFERASE gene. It is characterized by low HDL-cholesterol levels, and the triad of CORNEAL OPACITIES; HEMOLYTIC ANEMIA; and PROTEINURIA with renal failure. |
C0000435 | mapped_to | C0173734 | 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase | 3-ketoacyl-acyl carrier protein synthase III | An enzyme of long-chain fatty acid synthesis, that adds a two-carbon unit from malonyl-(acyl carrier protein) to another molecule of fatty acyl-(acyl carrier protein), giving a beta-ketoacyl-(acyl carrier protein) with the release of carbon dioxide. EC 2.3.1.41. | null |
C0000435 | mapped_to | C0210449 | 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase | beta-ketoacyl-acyl carrier protein synthase I | An enzyme of long-chain fatty acid synthesis, that adds a two-carbon unit from malonyl-(acyl carrier protein) to another molecule of fatty acyl-(acyl carrier protein), giving a beta-ketoacyl-(acyl carrier protein) with the release of carbon dioxide. EC 2.3.1.41. | null |
C0000435 | mapped_to | C0247552 | 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase | CEM1 protein, S cerevisiae | An enzyme of long-chain fatty acid synthesis, that adds a two-carbon unit from malonyl-(acyl carrier protein) to another molecule of fatty acyl-(acyl carrier protein), giving a beta-ketoacyl-(acyl carrier protein) with the release of carbon dioxide. EC 2.3.1.41. | null |
C0000435 | mapped_to | C1172591 | 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase | KAS2 protein, Arabidopsis | An enzyme of long-chain fatty acid synthesis, that adds a two-carbon unit from malonyl-(acyl carrier protein) to another molecule of fatty acyl-(acyl carrier protein), giving a beta-ketoacyl-(acyl carrier protein) with the release of carbon dioxide. EC 2.3.1.41. | null |
C0000435 | mapped_to | C1310350 | 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase | KasB protein, Mycobacterium tuberculosis | An enzyme of long-chain fatty acid synthesis, that adds a two-carbon unit from malonyl-(acyl carrier protein) to another molecule of fatty acyl-(acyl carrier protein), giving a beta-ketoacyl-(acyl carrier protein) with the release of carbon dioxide. EC 2.3.1.41. | null |
C0000435 | mapped_to | C1432013 | 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase | Hic protein, Arabidopsis | An enzyme of long-chain fatty acid synthesis, that adds a two-carbon unit from malonyl-(acyl carrier protein) to another molecule of fatty acyl-(acyl carrier protein), giving a beta-ketoacyl-(acyl carrier protein) with the release of carbon dioxide. EC 2.3.1.41. | null |
C0000435 | mapped_to | C1506617 | 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase | FabB protein, E coli | An enzyme of long-chain fatty acid synthesis, that adds a two-carbon unit from malonyl-(acyl carrier protein) to another molecule of fatty acyl-(acyl carrier protein), giving a beta-ketoacyl-(acyl carrier protein) with the release of carbon dioxide. EC 2.3.1.41. | null |
C0000435 | mapped_to | C1506618 | 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase | FabF protein, Enterococcus faecalis | An enzyme of long-chain fatty acid synthesis, that adds a two-carbon unit from malonyl-(acyl carrier protein) to another molecule of fatty acyl-(acyl carrier protein), giving a beta-ketoacyl-(acyl carrier protein) with the release of carbon dioxide. EC 2.3.1.41. | null |
C0000435 | mapped_to | C1956778 | 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase | KAB1 protein, Arabidopsis | An enzyme of long-chain fatty acid synthesis, that adds a two-carbon unit from malonyl-(acyl carrier protein) to another molecule of fatty acyl-(acyl carrier protein), giving a beta-ketoacyl-(acyl carrier protein) with the release of carbon dioxide. EC 2.3.1.41. | null |
C0000435 | mapped_to | C2355094 | 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase | FabH protein, Mycobacterium tuberculosis | An enzyme of long-chain fatty acid synthesis, that adds a two-carbon unit from malonyl-(acyl carrier protein) to another molecule of fatty acyl-(acyl carrier protein), giving a beta-ketoacyl-(acyl carrier protein) with the release of carbon dioxide. EC 2.3.1.41. | null |
C0000435 | mapped_to | C3180456 | 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase | fabH protein, E coli | An enzyme of long-chain fatty acid synthesis, that adds a two-carbon unit from malonyl-(acyl carrier protein) to another molecule of fatty acyl-(acyl carrier protein), giving a beta-ketoacyl-(acyl carrier protein) with the release of carbon dioxide. EC 2.3.1.41. | null |
C0000435 | mapped_to | C3657253 | 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase | KCS18 protein, Arabidopsis | An enzyme of long-chain fatty acid synthesis, that adds a two-carbon unit from malonyl-(acyl carrier protein) to another molecule of fatty acyl-(acyl carrier protein), giving a beta-ketoacyl-(acyl carrier protein) with the release of carbon dioxide. EC 2.3.1.41. | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.